View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 22, 2014

CHUV initiates Cerament |G Bone Healing study

Sweden-based Bonesupport has announced that the Centre Hospitalier Universitaire Vaudois (CHUV) in Switzerland has initiated the Cerament |G Bone Healing study, designed to investigate absorption and bone in-growth of Cerament|G in one-stage surgical revisions of infections.

By Mekala ShivaramPrasad

Sweden-based Bonesupport has announced that the Centre Hospitalier Universitaire Vaudois (CHUV) in Switzerland has initiated the Cerament |G Bone Healing study, designed to investigate absorption and bone in-growth of Cerament|G in one-stage surgical revisions of infections.

The Cerament|G Bone Healing study will follow patients for one-year post surgery. CT verified Cerament|G absorption and new bone in-growth are primary endpoints of the study.

Secondary and safety endpoints of the study are bone healing, post-operative infections and serum levels of gentamicin.

"We believe the use of Cerament|G will be of advantage for the patient when bone healing can be achieved with a one-stage procedure instead of a two-stage procedure, decreasing potential surgery-related complications."

CHUV septic unit head and principal clinical investigator for the Cerament|G Bone Healing study Dr Olivier Borens said: "We believe the use of Cerament|G will be of advantage for the patient when bone healing can be achieved with a one-stage procedure instead of a two-stage procedure, thus decreasing potential surgery-related complications."

Bonesupport chief medical officer Dr Mogens Gisselbaeck said: "We expect the results of this study will further qualify the positive outcomes reported from the Oxford Cerament|G study, and that mounting Cerament|G data may impact the surgical strategy related to the management of bone infections."

Cerament |G is an injectable antibiotic eluting ceramic bone graft substitute indicated to promote and protect bone healing in the management of osteomyelitis (bone infections).

Cerament |G obtained received CE Mark approval and is currently available in select markets. Currently, it is not available in the US.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU